The European Union (EU) has long been at the forefront of cosmetic regulation, ensuring consumer safety and maintaining high standards within the beauty industry. The latest amendment, Regulation (EU) 2024/996, introduces significant changes that private label brands, especially those utilizing Original Equipment Manufacturers (OEMs) in China, must understand to remain compliant and competitive in the EU market.

Understanding Regulation (EU) 2024/996

On April 3, 2024, the European Commission adopted Regulation (EU) 2024/996, amending the existing Cosmetic Regulation (EC) No 1223/2009. This amendment focuses on enhancing safety standards, fostering innovation, and reducing the environmental impact of cosmetic products. Key updates include:

• Prohibited Substances: The addition of certain substances to Annex II, effectively banning their use in cosmetic products. Notably, the UV-filter 4-Methylbenzylidene Camphor (4-MBC) has been prohibited due to safety concerns. 
• Restricted Substances: Revisions to Annex III, introducing new restrictions on specific ingredients based on the latest scientific recommendations.
• Endocrine Disruptors: Identification and regulation of substances with potential endocrine-disrupting properties, reflecting the EU's commitment to consumer health.

Implications for Private Label Brands Using China OEMs

For private label brands that rely on Chinese OEMs, these regulatory changes present both challenges and opportunities:​

1. Ingredient Compliance: Brands must ensure that their Chinese manufacturing partners are aware of and comply with the updated list of prohibited and restricted substances. This requires effective communication and collaboration to reformulate products if necessary.
2. Supply Chain Transparency: Enhanced traceability of raw materials is crucial. Brands should implement robust tracking systems to verify the origin and compliance of ingredients used in their products.​
3. Product Testing and Safety Assessments: OEMs must conduct comprehensive safety assessments in line with EU standards. Brands should verify that their manufacturers adhere to Good Manufacturing Practices (GMP) and maintain accurate documentation.​
4. Labeling and Packaging: Compliance with new labeling requirements is essential. Brands must ensure that product labels accurately reflect ingredient information and comply with EU regulations.​
5. Market Surveillance and Vigilance: Brands should establish procedures for post-market surveillance to monitor consumer feedback and adverse reactions, ensuring swift action if safety concerns arise.

Strategies for Compliance

To navigate these regulatory changes effectively, private label brands should consider the following strategies:

• Engage Regulatory Experts: Consulting with regulatory affairs specialists can provide valuable insights into compliance requirements and help develop effective strategies.​

• Strengthen Supplier Relationships: Building strong partnerships with Chinese OEMs is essential. Regular audits and clear communication can ensure adherence to EU standards.​

• Invest in Training: Educating internal teams and manufacturing partners about EU regulations fosters a culture of compliance and quality assurance.​

• Implement Robust Quality Control Systems: Establishing stringent quality control measures throughout the production process minimizes the risk of non-compliance.​

The introduction of Regulation (EU) 2024/996 underscores the EU's dedication to consumer safety and environmental sustainability in the cosmetic industry. Private label brands utilizing China OEMs must proactively adapt to these changes by ensuring ingredient compliance, enhancing supply chain transparency, and implementing rigorous quality control measures. By doing so, they can maintain market access, uphold brand reputation, and continue to thrive in the competitive EU cosmetic market.

​